Key Takeaways
- • Blackstone and CD&R are in early-stage discussions to explore potential bids for Magnum Ice Cream Company, the owner of Ben & Jerry's and Cornetto, less than six months after its December 2025 spinoff from Unilever.
- • Magnum's stock has declined from a high of €16.50 to approximately €13.00, near its December IPO price, providing potential entry valuations below the €7.8 billion IPO valuation and well below pre-listing analyst expectations of up to €10.8 billion.
- • Both firms are delaying bid decisions pending Magnum's summer sales reporting, as the ice cream category generates substantial seasonal revenue during this period, with other PE firms also monitoring the opportunity.
- • A leveraged buyout would position acquirers to execute cost reduction and margin expansion strategies to approach competitor Froneri's profitability profile, despite Magnum's leading 21% share of the $87 billion global ice cream market compared to Froneri's 11%.
- • Deal timing reflects broader PE deployment trends in Europe following years of subdued M&A activity, though Magnum faces headwinds from consumer health trends and GLP-1 weight-loss drug adoption affecting premium ice cream demand.
Summary
Blackstone and Clayton Dubilier & Rice (CD&R) have entered preliminary discussions to explore potential acquisition bids for Magnum Ice Cream Company, the ice cream portfolio owner spun out of Unilever in December 2025, according to two sources familiar with the matter. The exploration represents an early-stage effort, with both firms adopting a wait-and-see posture on valuation before committing to formal bids. Additional private equity firms are also expressing interest in the asset, though no formal process or sale timeline has been announced.
Magnum's stock performance since its December 8 IPO has created potential acquisition economics worth monitoring. The company priced at a €7.8 billion valuation—already below pre-IPO analyst expectations ranging to €10.8 billion—and shares have subsequently declined to trade near €13.00, down from a 2026 high of €16.50 and as low as €11.00. The depressed valuation relative to projections reflects both broader market conditions and sector-specific headwinds, including shifting consumer preferences toward healthier food options amid rising GLP-1 weight-loss drug adoption.
For potential acquirers, the investment thesis centers on operational improvement and margin expansion opportunities. Magnum generates approximately 21% of the global $87 billion ice cream market, positioning it ahead of rival Froneri's 11% share. However, according to sources, leveraged buyout firms view the company as a turnaround candidate capable of achieving cost reductions and profitability improvements comparable to Froneri's margin profile. Unilever, which retains a 19.9% stake following the spinoff, has committed to exiting its remaining position within five years, potentially creating a path to full privatization.
Strategic deliberations are explicitly tied to Magnum's upcoming summer sales performance. The ice cream category demonstrates pronounced seasonality, with summer months representing a disproportionate share of annual revenue. Both Blackstone and CD&R intend to assess second-half sales results before advancing to formal bid submissions. A successful privatization would constitute the latest in a series of European private equity take-privates as alternative asset managers seek to deploy capital following several years of constrained dealmaking in the region.
Magnum's stock performance since its December 8 IPO has created potential acquisition economics worth monitoring. The company priced at a €7.8 billion valuation—already below pre-IPO analyst expectations ranging to €10.8 billion—and shares have subsequently declined to trade near €13.00, down from a 2026 high of €16.50 and as low as €11.00. The depressed valuation relative to projections reflects both broader market conditions and sector-specific headwinds, including shifting consumer preferences toward healthier food options amid rising GLP-1 weight-loss drug adoption.
For potential acquirers, the investment thesis centers on operational improvement and margin expansion opportunities. Magnum generates approximately 21% of the global $87 billion ice cream market, positioning it ahead of rival Froneri's 11% share. However, according to sources, leveraged buyout firms view the company as a turnaround candidate capable of achieving cost reductions and profitability improvements comparable to Froneri's margin profile. Unilever, which retains a 19.9% stake following the spinoff, has committed to exiting its remaining position within five years, potentially creating a path to full privatization.
Strategic deliberations are explicitly tied to Magnum's upcoming summer sales performance. The ice cream category demonstrates pronounced seasonality, with summer months representing a disproportionate share of annual revenue. Both Blackstone and CD&R intend to assess second-half sales results before advancing to formal bid submissions. A successful privatization would constitute the latest in a series of European private equity take-privates as alternative asset managers seek to deploy capital following several years of constrained dealmaking in the region.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.